Back to search
FDAFDA · Food and drugs·Recall number D-0152-2017

Desoximetasone Ointment USP, 0.25%, a) 15 g tubes (NDC 61748-206-15 and b) 60 g tubes (NDC 61748-206-60, Marketed by Versapharm Inc., An Akorn Company, Lake Forest, IL, Manufactured by Hi-Tech, Pharmacal Co, Inc., Amityville, NY

Published November 30, 2016 · Recall initiated: November 14, 2016

Summary

FDA records drug Class II recall D-0152-2017, published November 30, 2016 and initiated November 14, 2016. Recalling firm: Akorn Inc; Status: Terminated; Reported quantity: a) 62 tubes and b) 91 tubes; Lot: Lot #348716 (exp. 12/2017). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specifications; out-of specification value for homogeneity / phase separation.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Akorn Inc
Distributor
Nationwide
Lot
Lot #348716 (exp. 12/2017)
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Desoximetasone Ointment USP, 0.25%, a) 15 g tubes (NDC 61748-206-15 and b) 60 g tubes (NDC 61748-206-60, Marketed by Versapharm Inc., An Akorn Company, Lake Forest, IL, Manufactured by Hi-Tech, Pharmacal Co, Inc., Amityville, NY recalled?

Yes. FDA published recall D-0152-2017 on November 30, 2016. Reported hazard: Failed Stability Specifications; out-of specification value for homogeneity / phase separation.

What should I do if I have this product?

Voluntary: Firm initiated · Letter